相关实验视频
Updated: Mar 6, 2026

06:11
A Conflict Model of Reward-seeking Behavior in Male Rats
Published on: February 20, 2019
7.9K
普罗米修斯被解开了吗? 海洋情感和成的神经心理动力学
Human-Friedrich Unterrainer1,2,3,4
1Faculty of Psychotherapy Science, Sigmund Freud Private University, Vienna, Austria.
Frontiers in psychology
|March 5, 2026
概括
成可能是超越的失败尝试,利用改变的意识来应对碎片化. 在成中,海洋状态提供了暂时的缓解,但阻碍了整合,这表明了复杂的神经心理动力学过程.
科学领域:
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
- 精神病学是一个精神病学.
背景情况:
- 意识的变化状态,包括海洋情感 (自我解体,无界),是从精神病到神秘联盟的经验的核心.
- 这些状态可以由迷幻药物,创伤,冥想或成引起,提供暂时的缓解,但可能会加强回归.
- 沉迷的海洋状态可能代表对心理痛苦的防御和对完整性的渴望,作为失败的超越而起作用.
研究的目的:
- 将成概念化,不仅仅是不适应性行为,而且是神经心理动力学试图恢复内部凝聚力的尝试.
- 将精神动力学理论与神经科学发现相结合,以了解海洋状态在成中的作用.
- 通过过渡现象的透视来提供对成过程及其治疗影响的细微视角.
主要方法:
- 心理动力学理论与当前神经科学发现的整合.
- 基于普罗米修斯神话的概念分析.
- 检查成中改变意识状态的神经生物学相关性.
主要成果:
- 成的循环,类似于普罗米修斯的永恒的痛苦,涉及神经生物学和象征性的自我毁灭.
- 神经科学发现表明,这些状态中的默认模式网络发生了变化,边缘失调,自上而下的控制减少,神经度增加.
- 这些变化可以放松自我结构,促进无意识的物质出现,并可能有助于恢复内部凝聚力.
结论:
- 沉迷的海洋状态是崩和转变的边界上的过渡现象.
- 成可以被视为一种神经心理动态的努力,以实现精神完整,虽然不适应.
- 对这些状态的细微了解对于开发有效的成治疗干预措施至关重要.
更多相关视频
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K
Drug Dependence
1.8K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
Substance Use Disorders Affecting Sleep
500
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
500
Neurochemical Transmission: Sites of Drug Action
3.8K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.8K
Drugs Affecting Neurotransmitter Synthesis
2.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K

